{
    "Title": "Melarsoprol Cyclodextrin Inclusion Complexes as Promising Oral Candidates for the Treatment of Human African Trypanosomiasis",
    "URL": "https://doi.org/10.1371/journal.pntd.0001308",
    "Published": "September 6, 2011",
    "Subject_Areas": [
        "Trypanosoma",
        "Drug therapy",
        "Parasitic diseases",
        "Chemotherapy",
        "Drug administration",
        "Magnetic resonance imaging",
        "Blood-brain barrier",
        "Central nervous system"
    ],
    "Authors": {
        "Jean Rodgers": [
            "Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom"
        ],
        "Amy Jones": [
            "Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom"
        ],
        "Stéphane Gibaud": [
            "Laboratoire de Pharmacie Clinique, Nancy Université, Nancy, France"
        ],
        "Barbara Bradley": [
            "Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom"
        ],
        "Christopher McCabe": [
            "Institute of Neuroscience and Psychology, Glasgow Experimental MRI Centre, University of Glasgow, Glasgow, United Kingdom"
        ],
        "Michael P. Barrett": [
            "Wellcome Trust Centre of Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom"
        ],
        "George Gettinby": [
            "Department of Mathematics and Statistics, University of Strathclyde, Glasgow, United Kingdom"
        ],
        "Peter G. E. Kennedy": [
            "Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom"
        ]
    }
}